Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03867578 · ClinicalTrials.gov registry record · NA
Magnetic Resonance Imaging for Detection of Peritoneal Mesothelioma
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT03867578 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 26 participants.
The verdict
NCT03867578, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
For cancers, such as mesothelioma, that spread to the lining of the stomach, detecting the cancer is very difficult with CT or MRI scans. Researchers at the University of Chicago want to find out if the new experimental MRI and ultrasound imaging techniques do a better job of detecting these cancers. Researchers will use new MRI and ultrasound techniques to see if it can find evidence of cancer that has spread to the lining of the abdomen, and right now these new techniques are only used for research.
Interventions
- DIAGNOSTIC_TEST Ultrasound
- DIAGNOSTIC_TEST HR-MRI
- DIAGNOSTIC_TEST Standard CT Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2018-10-10 |
| Est. Completion | 2022-07-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03867578
The ClinicalTrials.gov registry entry for NCT03867578 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ultrasound is the first listed.
NCT03867578 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03867578 about?
NCT03867578 is a clinical study titled "Magnetic Resonance Imaging for Detection of Peritoneal Mesothelioma". For cancers, such as mesothelioma, that spread to the lining of the stomach, detecting the cancer is very difficult with CT or MRI scans. Researchers at the University of Chicago want to find out if the new experimental MRI and ultrasound imaging techniques do a better job of detecting these cancers...
What is the current status of trial NCT03867578?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2018-10-10. Estimated completion is 2022-07-20.
What interventions are being tested in trial NCT03867578?
The interventions under investigation include: Ultrasound (DIAGNOSTIC_TEST), HR-MRI (DIAGNOSTIC_TEST), Standard CT Imaging (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03867578?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.